AmerisourceBergen Corp. (ABC)

78.97
2.92 3.57
NYSE : Distribution Services
Prev Close 81.89
Open 80.78
Day Low/High 78.77 / 81.33
52 Wk Low/High 77.28 / 106.27
Volume 1.56M
Avg Volume 1.32M
Exchange NYSE
Shares Outstanding 211.93M
Market Cap 17.64B
EPS 7.60
P/E Ratio 11.05
Div & Yield 1.60 (1.87%)
A New PD-L1 BOND Ready-to-Use Antibody, Providing You With The Freedom And Flexibility To Develop The Tests You Need

A New PD-L1 BOND Ready-to-Use Antibody, Providing You With The Freedom And Flexibility To Develop The Tests You Need

NEWCASTLE, England, Nov. 13, 2018 /PRNewswire/ -- Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform.

AmerisourceBergen Reports Fiscal 2018 Fourth Quarter And Year End Results

AmerisourceBergen Reports Fiscal 2018 Fourth Quarter And Year End Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2018 fourth quarter ended September 30, 2018, revenue increased 10.

CURRENT SHAREHOLDERS: Zamansky LLC Investigates AmerisourceBergen (ABC) For Potential Breaches Of Fiduciary Duties

CURRENT SHAREHOLDERS: Zamansky LLC Investigates AmerisourceBergen (ABC) For Potential Breaches Of Fiduciary Duties

Zamansky LLC announces that it is investigating AmerisourceBergen Corporation (NYSE:ABC) ("AmerisourceBergen" or the "Company") for potential breaches of fiduciary duties by its senior officers and board of directors.

Scott Scott Attorneys At Law LLP Investigating Derivative Claims On Behalf Of Shareholders Of AmerisourceBergen Corporation - ABC

Scott Scott Attorneys At Law LLP Investigating Derivative Claims On Behalf Of Shareholders Of AmerisourceBergen Corporation - ABC

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of AmerisourceBergen Corporation ("AmerisourceBergen" or the "Company") (NYSE:ABC)...

AmerisourceBergen Applauds Signing Of Bipartisan Legislation To Combat Opioid Abuse

AmerisourceBergen Applauds Signing Of Bipartisan Legislation To Combat Opioid Abuse

AmerisourceBergen, a global healthcare solutions leader, released the following comment regarding the signing of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment ("SUPPORT") for Patients and Communities Act (H.

Haeggquist & Eck, LLP Investigates AmerisourceBergen Corporation's Directors And Officers For Breach Of Fiduciary Duty Regarding Double-Billing, Kickbacks, And Criminal Fines And Forfeitures

Haeggquist & Eck, LLP Investigates AmerisourceBergen Corporation's Directors And Officers For Breach Of Fiduciary Duty Regarding Double-Billing, Kickbacks, And Criminal Fines And Forfeitures

Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of AmerisourceBergen Corporation ("Amerisource" or the "Company") (NYSE: ABC) breached their fiduciary duties to Amerisource and...

Scott Scott Attorneys At Law LLP Investigating Derivative Claims On Behalf Of Shareholders Of AmerisourceBergen Corporation - ABC

Scott Scott Attorneys At Law LLP Investigating Derivative Claims On Behalf Of Shareholders Of AmerisourceBergen Corporation - ABC

NEW YORK, Oct. 4, 2018 /PRNewswire/ --  Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of AmerisourceBergen Corporation...

AmerisourceBergen Announces Date And Time For Fourth Quarter Fiscal 2018 Earnings Release

AmerisourceBergen Announces Date And Time For Fourth Quarter Fiscal 2018 Earnings Release

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter Fiscal 2018 on Tuesday, November 6, 2018, prior to the opening of trading on the New York Stock Exchange.

Former AmerisourceBergen Executive Blows The Whistle On Massive Drug Overfill Laundering Scheme, Leading To $885 Million Combined Civil And Criminal Settlement

Former AmerisourceBergen Executive Blows The Whistle On Massive Drug Overfill Laundering Scheme, Leading To $885 Million Combined Civil And Criminal Settlement

WASHINGTON, Oct. 1, 2018 /PRNewswire/ -- Whistleblower Law Collaborative and Kellogg, Hansen, Todd, Figel & Frederick, P.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

AmerisourceBergen Announces Financial Leadership Change

AmerisourceBergen Announces Financial Leadership Change

AmerisourceBergen Corporation (NYSE: ABC) today announced that Tim G. Guttman, Executive Vice President and Chief Financial Officer, has decided to retire from the Company.

'Death by Amazon' Greatly Exaggerated

'Death by Amazon' Greatly Exaggerated

Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.

AmerisourceBergen Declares Quarterly Dividend

AmerisourceBergen Declares Quarterly Dividend

The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.

CAH Is Among the Best Blue Chip Values

CAH Is Among the Best Blue Chip Values

Buy Cardinal Health and give it time for the market to reassess the industry.

AmerisourceBergen Reports Fiscal 2018 Third Quarter Results

AmerisourceBergen Reports Fiscal 2018 Third Quarter Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2018 third quarter ended June 30, 2018, revenue increased 11.

AmerisourceBergen Announces Date And Time For Third Quarter Fiscal 2018 Earnings Release

AmerisourceBergen Announces Date And Time For Third Quarter Fiscal 2018 Earnings Release

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2018 on Thursday, August 2, 2018 prior to the opening of trading on the New York Stock Exchange.

Four Cheap 'Dividend Aristocrats' to Buy Now

Four Cheap 'Dividend Aristocrats' to Buy Now

These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.

Four Cheap ‘Dividend Aristocrats’ to Buy Now

These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.

Play the Dip on AmerisourceBergen

Play the Dip on AmerisourceBergen

A low risk stock with a moderate upside makes sense.

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.

What to Expect From Trump's Speech on Drug Prices on Friday

What to Expect From Trump's Speech on Drug Prices on Friday

Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.

AmerisourceBergen Declares Quarterly Dividend

AmerisourceBergen Declares Quarterly Dividend

The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.

Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

One drug distribution executive appearing before a House Committee to answer for shipping millions of doses of opioids into West Virginia apologized and another said his company had a hand in the crisis.

Cardinal Health Plunges After Negative Earnings Revision

Cardinal Health Plunges After Negative Earnings Revision

Cardinal Health had its worst day of trading in 14 years.

AmerisourceBergen Reports Fiscal 2018 Second Quarter Results

AmerisourceBergen Reports Fiscal 2018 Second Quarter Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2018 second quarter ended March 31, 2018, revenue increased 10.

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

An internal review of management behavior at the healthcare company over opioid distribution prompted by complaints from shareholder International Brotherhood of Teamsters gives company officials a clean bill of health.

Congress Sets Opioid Hearing Next Month for Drug Distributors

Congress Sets Opioid Hearing Next Month for Drug Distributors

A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.

Walmart and Target Look Like They Are Freaking Out Because of Amazon

Walmart and Target Look Like They Are Freaking Out Because of Amazon

The rumors are coming in hot and heavy on possible moves Walmart and Target are making to keep at Amazon at bay. Meanwhile, stocks just closed below this key point. Rejoice, bears.

TheStreet Quant Rating: B- (Buy)